I would not read too much into these difference. You get variations in these synergy assays when you repeat them especially around the max value. What is more important is the robustness of the synergy across different concentrations of the drugs.
- Forums
- ASX - By Stock
- RAC
- Ann: Bisantrene shows potent anticancer activity in AML models
Ann: Bisantrene shows potent anticancer activity in AML models, page-23
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.79 |
Change
0.035(2.00%) |
Mkt cap ! $302.3M |
Open | High | Low | Value | Volume |
$1.82 | $1.82 | $1.78 | $22.55K | 12.61K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 59 | $1.76 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.78 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 59 | 1.760 |
2 | 3955 | 1.755 |
1 | 9998 | 1.750 |
1 | 1100 | 1.745 |
1 | 334 | 1.735 |
Price($) | Vol. | No. |
---|---|---|
1.780 | 200 | 1 |
1.785 | 1443 | 1 |
1.790 | 1000 | 1 |
1.795 | 142 | 1 |
1.800 | 2111 | 2 |
Last trade - 11.12am 10/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online